Previous studies have demonstrated that FXR activation negatively regulates ER stress by disrupting the PERK/eIF2α/CHOP pathway, thereby helping to control gastritis, liver injury, and fatty liver in mice [[20], [21], [22]]. This evidence concerns the gene NR1H4 and Hepatic steatosis.